An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Clinical trial NCT02854436 · COMPLETED
Trial details
- NCT number
- NCT02854436
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-31
- Primary completion
- 2021-01-26
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.